Table 1 Association between HOTAIR expression and clinicopathological features of CCA.
Clinicopathological features | No. of patients(n) | HOTAIR expression | p-value | |
|---|---|---|---|---|
High (n) | Low (n) | |||
Gender | ||||
  Male | 33 | 20 | 13 | 0.544 |
  Female | 37 | 23 | 14 |  |
Age | ||||
  <60 | 32 | 21 | 11 | 0.624 |
  ≥60 | 38 | 22 | 16 |  |
Tumor site | ||||
  Intrahepatic | 20 | 12 | 8 | 0.952 |
  Perihilar | 22 | 13 | 9 |  |
  Distal | 28 | 18 | 10 |  |
Tumor size | ||||
  <3 | 32 | 15 | 17 | 0.028 |
  ≥3 | 38 | 28 | 10 |  |
Vascular invasion | ||||
  Positive | 30 | 20 | 10 | 0.468 |
  Negative | 40 | 23 | 17 |  |
Lymph node invasion | ||||
  Present | 31 | 20 | 11 | 0.805 |
  Absent | 39 | 23 | 16 |  |
TNM stage | ||||
  I–II | 26 | 11 | 15 | 0.021 |
  III–IV | 44 | 32 | 12 |  |
Differentiation grade | ||||
  Well/moderately | 25 | 14 | 11 | 0.609 |
  Poorly/undifferentiated | 45 | 29 | 16 |  |
Postoperative recurrence | ||||
  Present | 53 | 37 | 16 | 0.020 |
  Absent | 17 | 6 | 11 |  |
Serum CEA level | ||||
  >5 ng/ml | 42 | 25 | 17 | 0.804 |
  ≤5 ng/ml | 28 | 18 | 10 |  |
Serum CA19-9 level | ||||
  >37 U/ml | 46 | 27 | 19 | 0.609 |
  ≤37 U/ml | 24 | 16 | 8 |  |
HBV infection | ||||
  Positive | 21 | 12 | 9 | 0.789 |
  Negative | 49 | 31 | 18 |  |